AksharChem India Ltd
- P/E
- 13.5x
- 52-week range
- 141.3 – 472
- ROE
- −1%
- ROCE
- 0%
- Sector
- Chemicals & Petrochemicals
- Industry
- Dyes And Pigments
- Listed on
- NSE, BSE
About
AksharChem (India) Limited is an India-based company, which is engaged in manufacturing of dyes, pigments and inorganic chemicals. The Company operates in the chemical business segment. Its products include dye intermediates that include H Acid, Vinyl Sulphone (Acetanilide Base), Ortho Anicidine Vinyl Sulphone (OAVS), and Sulpho Para Vinyl Sulphone (Sulpho VS); Dyes, which includes Reactive Blue 21 and Reactive Black 5; Pigment and Precipitated Silica. It serves the textile, printing, ink, paint, rubber, plastics, leather and tire industries. It has two manufacturing facilities, one in Mehsana for Vinyl Sulphone, CPC Green and H-Acid and the other at Dahej for Precipitated Silica. The Company’s products are sold in India and exported across 25 plus countries, including Europe, the United States of America (USA), the Middle East and Africa, and Asia Pacific.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Dyes And Pigments: 19 companies →AksharChem India Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)13.5 against a typical 15.3: cheaper than most peers (1st = cheapest).9th of 19
- Sales growth+79.8% against a typical +29.6% from a year earlier.2nd of 17
- Share price, 3 months+55.5% against a typical +6%.3rd of 19
Latest announcements
Exchange filings and their impact on the company.
- Turnaround sustained with Rs 301 cr H1 revenue and Rs 28.5 cr profit pointing to sharply higher full-year earnings.
AksharChem reported strong September quarter results with Q2 revenue of Rs 160.48 cr and net profit of Rs 13.32 cr, taking half-year revenue to Rs 301.35 cr and net profit to Rs 28.53 cr versus a loss last year. The balance sheet also strengthened with net worth rising to Rs 290 cr and borrowings easing to Rs 103.8 cr. The board also re-appointed Munjal Jaykrishna as Managing Director & CEO and Sachin Jaykrishna as Whole Time Director, ensuring leadership continuity.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Adequate safety, with caution
Rated A- by CARE- CARE expects things to get worse (negative outlook).
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | CARE A- | Negative | 26 Feb 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 26 Feb 2026 | Reaffirmed | CARE A- | — | CARE | ₹ 143.41 Cr. | |
| 6 Feb 2026 | Reaffirmed | CARE A- | — | CARE | ₹ 123.41 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 19 Oct 2026 | Financial Results | To consider and approve the financial results for the period ended September 30, 2026 |
| 12 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 21 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 28 Jan 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 12 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 25 Jul 2025 | Financial Results | To consider, approve and take on record the Unaudited financial results for the quarter ended on June 30, 2025 and other businesses, if any |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 75 | 82 | 86 | 79 | 91 | 91 | 97 | 89 | 80 | 106 | 141 | 160 |
| Expenses | 70 | 81 | 80 | 73 | 84 | 84 | 91 | 87 | 77 | 100 | 118 | 140 |
| Operating Profit | 5 | 0 | 6 | 6 | 6 | 6 | 6 | 2 | 3 | 5 | 23 | 21 |
| OPM % | 7% | 0.5% | 7% | 8% | 7% | 7% | 7% | 2.6% | 3.6% | 5% | 16% | 13% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Depreciation | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | 1 | −4 | 2 | 1 | 2 | 1 | 1 | −1 | −3 | −1 | 16 | 14 |
| Tax % | 57% | 50% | 28% | 26% | 22% | −7% | 31% | −3% | 50% | −584% | 5% | 5% |
| Net Profit | 0 | −6 | 1 | 1 | 1 | 1 | 1 | −1 | −5 | 5 | 15 | 13 |
| EPS in Rs | 0.41 | −7.49 | 1.43 | 1.29 | 1.48 | 1.73 | 0.88 | −1.71 | −5.75 | 6.03 | 18.93 | 16.58 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 7%
- 5 Years
- 9%
- 3 Years
- 4%
- TTM
- 33%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- 12,968%
- 10 Years
- −4%
- 5 Years
- −5%
- 3 Years
- 13%
- TTM
- —
- 10 Years
- 5%
- 5 Years
- 0%
- 3 Years
- −2%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| AksharChem India Ltd | ₹ 383.80 | — | 13.5x | — | −1% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 53.4x | 11.1x | 0% | 0% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 114.5x | 32.1x | 0% | 0% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 64.8x | 14.7x | 0% | 0% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 38.5x | 5.2x | 0% | 0% |
| Coromandel International | ₹ 1,723.60 | ₹ 50,876 Cr. | 28x | 4.5x | 0% | 0% |
Management
- Paru M. Jaykrishna
- Executive Chairman of the Board, Founder, Managing Director
- Munjal Mrugesh Jaykrishna
- Chief Executive Officer, Joint Managing Director, Executive Director
- Amit D. Soni
- Chief Financial Officer
- Mehul Chandulal Naliyadhara
- Compliance Officer, Company Secretary
- Sachin M. Jaykrishna
- Whole Time Director
- Devalkumar Indrabal Suthar
- Additional Whole Time Director - Executive
Prices are delayed and for information only. Nothing on this page is investment advice.